HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome.

Abstract
Dementia and brain atrophy are established features of a large proportion of patients with acquired immune deficiency syndrome (AIDS). To investigate a potential mechanism for atrophy in AIDS, we measured the concentration of the endogenous neurotoxin quinolinic acid in the cerebrospinal fluid of 10 patients with AIDS and found that they had 3-fold higher quinolinic acid concentrations than 9 age-matched control subjects: 53.8 +/- 10.7 pmol/ml versus 18.4 +/- 3.4 pmol/ml, respectively (p less than 0.005). It remains to be determined whether increased brain quinolinic acid concentrations are involved in the pathogenesis of the neuropathology of AIDS.
AuthorsM P Heyes, D Rubinow, C Lane, S P Markey
JournalAnnals of neurology (Ann Neurol) Vol. 26 Issue 2 Pg. 275-7 (Aug 1989) ISSN: 0364-5134 [Print] UNITED STATES
PMID2528321 (Publication Type: Journal Article)
Chemical References
  • Pyridines
  • Quinolinic Acids
  • Tryptophan
  • Quinolinic Acid
Topics
  • Acquired Immunodeficiency Syndrome (cerebrospinal fluid)
  • Adult
  • Female
  • Humans
  • Male
  • Pyridines (cerebrospinal fluid)
  • Quinolinic Acid
  • Quinolinic Acids (cerebrospinal fluid)
  • Tryptophan (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: